XML 44 R2.htm IDEA: XBRL DOCUMENT v3.26.1
Pay vs Performance Disclosure
12 Months Ended
Dec. 31, 2025
USD ($)
Dec. 28, 2024
USD ($)
Dec. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
Jan. 01, 2022
USD ($)
Pay vs Performance Disclosure          
Pay vs Performance Disclosure, Table
YearSummary Compensation Table Total for Ivo Jurek¹
($)
Compensation Actually Paid to Ivo Jurek¹˒²˒3
($)
Average Summary Compensation Table Total for Non-PEO NEOs2,³, 4
($)
Average Compensation Actually Paid to Non-PEO NEOs²˒³˒4
($)
Value of Initial Fixed $100 Investment based on:5
Net Income
($ Millions)
Company Selected Measure: Adjusted ROIC6
(%)
TSR
($)
Peer Group TSR
($)
20259,911,35812,598,1182,762,8312,354,639168.26219.76276.322.9 
20249,962,63822,976,9102,346,8504,513,500161.99183.79219.924.0 
20239,711,01412,554,9732,212,8432,610,559105.17158.19256.423.0 
202214,402,39023,468,5812,840,8012,999,90689.42114.87242.520.0 
20218,772,29911,819,9412,711,1943,205,263124.69127.67331.322.4 
       
Company Selected Measure Name Adjusted ROIC        
Named Executive Officers, Footnote Ivo Jurek was our PEO for each year presented.Non-PEO NEOs for each year presented are listed below.
20212022202320242025
L. Brooks MallardL. Brooks Mallard
L. Brooks Mallard
L. Brooks Mallard
L. Brooks Mallard
Walter LifseyWalter Lifsey
Thomas G. Pitstick
Thomas G. Pitstick
Thomas G. Pitstick
Grant GawronskiGrant Gawronski
Cristin C. Bracken
Cristin C. Bracken
Cristin C. Bracken
Thomas G. PitstickThomas G. Pitstick
Gwen Montgomery
Gwen Montgomery
Gwen Montgomery
Cristin C. Bracken
       
Peer Group Issuers, Footnote The Peer Group TSR set forth in this table utilizes the S&P 400 Capital Goods Industry Index (“Peer Group”), which we also utilize in the stock performance graph required by Item 201(e) of Regulation S-K included in our 2025 Annual Report. The comparison assumes $100 was invested for the period starting December 31, 2020 (the last trading day of our fiscal year 2020), through the end of the listed year in the Company and in the Peer Group, respectively, including the reinvestment of dividends. Historical stock performance is not necessarily indicative of future stock performance.        
PEO Total Compensation Amount $ 9,911,358 $ 9,962,638 $ 9,711,014 $ 14,402,390 $ 8,772,299
PEO Actually Paid Compensation Amount $ 12,598,118 22,976,910 12,554,973 23,468,581 11,819,941
Adjustment To PEO Compensation, Footnote CAP reflects the exclusions and inclusions of certain amounts for the PEO and the Non-PEO NEOs as set forth below. Equity values are calculated in accordance with FASB ASC Topic 718. Amounts shown for exclusion of stock awards below are the totals from the Stock Awards column set forth in the Summary Compensation Table.
The amounts in the inclusion of equity values in the tables above are derived from the amounts set forth in the following tables:
YearYear-End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year for Ivo Jurek
($)
Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards for Ivo Jurek
($)
Vesting-Date Fair Value of Equity Awards Granted During Year that Vested During Year for Ivo Jurek
($)
Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year for Ivo Jurek
($)
Fair Value at Last Day of Prior Year of Equity Awards Forfeited During Year for Ivo Jurek
($)
Total - Inclusion of Equity Values for Ivo Jurek
($)
20257,812,117325,1451,222,6989,359,960
       
Non-PEO NEO Average Total Compensation Amount $ 2,762,831 2,346,850 2,212,843 2,840,801 2,711,194
Non-PEO NEO Average Compensation Actually Paid Amount $ 2,354,639 4,513,500 2,610,559 2,999,906 3,205,263
Adjustment to Non-PEO NEO Compensation Footnote CAP reflects the exclusions and inclusions of certain amounts for the PEO and the Non-PEO NEOs as set forth below. Equity values are calculated in accordance with FASB ASC Topic 718. Amounts shown for exclusion of stock awards below are the totals from the Stock Awards column set forth in the Summary Compensation Table.
YearAverage Summary Compensation Table Total for Non-PEO NEOs
($)
Average Exclusion of Stock Awards for Non-PEO NEOs
($)
Average Inclusion of Equity Values for Non-PEO NEOs
($)
Average CAP to Non-PEO NEOs
($)
20252,762,831 (1,514,424)1,106,232 2,354,639 
YearAverage Year-End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year for Non-PEO NEOs
($)
Average Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards for Non-PEO NEOs
($)
Average Vesting-Date Fair Value of Equity Awards Granted During Year that Vested During Year for Non-PEO NEOs
($)
Average Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year for Non-PEO NEOs
($)
Average Fair Value at Last Day of Prior Year of Equity Awards Forfeited During Year for Non-PEO NEOs
($)
Total - Average Inclusion of Equity Values for Non-PEO NEOs
($)
20251,088,913 37,189 33,954 207,370 (261,194)1,106,232 
       
Compensation Actually Paid vs. Total Shareholder Return
3191
       
Compensation Actually Paid vs. Net Income
3193
       
Compensation Actually Paid vs. Company Selected Measure
3195
       
Total Shareholder Return Vs Peer Group
3191
       
Tabular List, Table
Most Important Performance Measures
Adjusted ROIC
Adjusted EBITDA
Relative TSR
Free Cash Flow
Revenue
       
Total Shareholder Return Amount $ 168.26 161.99 105.17 89.42 124.69
Peer Group Total Shareholder Return Amount 219.76 183.79 158.19 114.87 127.67
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $ 276,300,000 $ 219,900,000 $ 256,400,000 $ 242,500,000 $ 331,300,000
Company Selected Measure Amount 0.229 0.240 0.230 0.200 0.224
PEO Name Ivo Jurek        
Additional 402(v) Disclosure The amounts shown for compensation actually paid (“CAP”) above have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually earned, realized, or received by the Company’s NEOs. These amounts reflect the Summary Compensation Table Total for the PEO and the average of the Summary Compensation Table Totals for the non-PEO NEOs, in each case, with certain adjustments as described in footnote 3 below.        
Measure:: 1          
Pay vs Performance Disclosure          
Name Adjusted ROIC        
Non-GAAP Measure Description We determined Adjusted ROIC to be the most important financial performance measure used to link the Company’s performance to CAP for our PEO and Non-PEO NEOs in 2025. More information on Adjusted ROIC, including a description of how it was calculated in 2025, can be found under the “Elements of Compensation - Long-Term Incentive Opportunity” section of the CD&A. We may determine a different financial performance measure to be the most important financial performance measure in future years.        
Measure:: 2          
Pay vs Performance Disclosure          
Name Adjusted EBITDA        
Measure:: 3          
Pay vs Performance Disclosure          
Name Relative TSR        
Measure:: 4          
Pay vs Performance Disclosure          
Name Free Cash Flow        
Measure:: 5          
Pay vs Performance Disclosure          
Name Revenue        
PEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount $ (6,673,200)        
PEO | Equity Awards Adjustments, Excluding Value Reported in Compensation Table          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 9,359,960        
PEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 7,812,117        
PEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 325,145        
PEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0        
PEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 1,222,698        
PEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0        
Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (1,514,424)        
Non-PEO NEO | Equity Awards Adjustments, Excluding Value Reported in Compensation Table          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 1,106,232        
Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 1,088,913        
Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 37,189        
Non-PEO NEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 33,954        
Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 207,370        
Non-PEO NEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount $ (261,194)